PMID- 2170004
OWN - NLM
STAT- MEDLINE
DCOM- 19901115
LR  - 20201209
IS  - 0304-3835 (Print)
IS  - 0304-3835 (Linking)
VI  - 53
IP  - 2-3
DP  - 1990 Sep
TI  - Systemic treatment of a human epidermoid non-small cell lung carcinoma xenograft 
      with a xanthate compound causes extensive intratumoral necrosis.
PG  - 97-102
AB  - Therapeutic effects were obtained after systemic treatment of athymic mice 
      bearing an epidermoid non-small cell human lung carcinoma (NSCLC) xenograft with 
      tricyclodecan-9-yl xanthogenate (D609) and the potassium salt of a fatty 
      (dodecanoic) acid. Extensive intratumoral necrosis was observed 3 days after the 
      treatment.
FAU - Sauer, G
AU  - Sauer G
AD  - Institute for Virus Research, German Cancer Research Center, Heidelberg.
FAU - Amtmann, E
AU  - Amtmann E
FAU - Hofmann, W
AU  - Hofmann W
LA  - eng
PT  - Journal Article
PL  - Ireland
TA  - Cancer Lett
JT  - Cancer letters
JID - 7600053
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Bridged-Ring Compounds)
RN  - 0 (Drug Combinations)
RN  - 0 (Lauric Acids)
RN  - 0 (Norbornanes)
RN  - 0 (Thiocarbamates)
RN  - 0 (Thiones)
RN  - 1160N9NU9U (lauric acid)
RN  - 5QC1Z07M77 (tricyclodecane-9-yl-xanthogenate)
SB  - IM
MH  - Animals
MH  - *Antineoplastic Agents
MH  - Bridged-Ring Compounds/*therapeutic use
MH  - Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology
MH  - Drug Combinations
MH  - Humans
MH  - Lauric Acids/administration & dosage/*therapeutic use
MH  - Lung Neoplasms/*drug therapy/pathology
MH  - Mice
MH  - Mice, Nude
MH  - Necrosis
MH  - Neoplasm Transplantation
MH  - Norbornanes
MH  - Thiocarbamates
MH  - Thiones/*therapeutic use
EDAT- 1990/09/01 00:00
MHDA- 1990/09/01 00:01
CRDT- 1990/09/01 00:00
PHST- 1990/09/01 00:00 [pubmed]
PHST- 1990/09/01 00:01 [medline]
PHST- 1990/09/01 00:00 [entrez]
AID - 0304-3835(90)90200-H [pii]
AID - 10.1016/0304-3835(90)90200-h [doi]
PST - ppublish
SO  - Cancer Lett. 1990 Sep;53(2-3):97-102. doi: 10.1016/0304-3835(90)90200-h.